Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eton Pharmaceuticals, Inc.

15.58
+0.98006.71%
Post-market: 15.580.00000.00%18:48 EDT
Volume:191.03K
Turnover:2.94M
Market Cap:402.53M
PE:-73.33
High:15.63
Open:14.85
Low:14.68
Close:14.60
Loading ...

Company Profile

Company Name:
Eton Pharmaceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
30
Office Location:
21925 W. Field Parkway,Suite 235,Deer Park,Illinois,United States
Zip Code:
60010-7278
Fax:
- -
Introduction:
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Directors

Name
Position
Norbert G. Riedel
Director, Chairman of the Board
Sean E. Brynjelsen
President, Chief Executive Officer and Director
Charles J. Casamento
Director
Mark L. Baum
Director
Paul V. Maier
Director

Shareholders

Name
Position
Sean E. Brynjelsen
President, Chief Executive Officer and Director
W. Wilson Troutman
Chief Financial Officer, Treasurer, and Secretary